Alfredo Halpern

Northwell Health — United States

Medicine · Health Sciences

47h-index8.7kcitations219works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diet and metabolism studies(41), Pharmacology and Obesity Treatment(39), Bariatric Surgery and Outcomes(29), Diabetes Treatment and Management(28), Metabolism, Diabetes, and Cancer(18)

Publications219 total

Ambulatory Curriculum Enhancing Education for Modern Resident Learners
PRiMER·2025Open Access
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
The Lancet·2017· 816 cited
Obesidade no Adulto
Manole eBooks·2016
Cognitive Effects of Intentional Weight Loss in Elderly Obese Individuals With Mild Cognitive Impairment
The Journal of Clinical Endocrinology & Metabolism·2015· 163 citedOpen Access
Additional analyses of the weight-lowering efficacy of liraglutide 3.0 mg in overweight and obese adults: the SCALE obesity and prediabetes randomized trial
Diabetologie und Stoffwechsel·2015· 1 cited
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
New England Journal of Medicine·2015· 2.5k citedOpen Access
Associations between a common variant near the MC4R gene and serum triglyceride levels in an obese pediatric cohort
Endocrine·2015· 26 citedOpen Access
Additional Analyses of the Weight-lowering Efficacy of Liraglutide 3.0 mg in Adults with Overweight and Obesity: The SCALE Obesity and Prediabetes Randomized Trial
Canadian Journal of Diabetes·2015· 1 cited
Liraglutide 3.0 mg Reduces Body Weight and Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity: The SCALE Obesity and Prediabetes Randomised Trial
Canadian Journal of Diabetes·2015· 8 cited
Liraglutide 3.0 mg Reduces Body Weight and Improves Health-Related Quality of Life (HRQoL) in Overweight or Obese Adults without Diabetes: The SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled, 56-Week Trial
Canadian Journal of Diabetes·2015· 4 cited
Efficacy and safety of liraglutide 3.0 mg for weight management in overweight and obese adults: the SCALE™ Obesity and Prediabetes, a randomised, double-blind and placebo-controlled trial
Experimental and Clinical Endocrinology & Diabetes·2015· 1 cited
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Expert Opinion on Drug Safety·2015· 48 cited
Why are anti-obesity drugs stigmatized?
Expert Opinion on Drug Safety·2014· 52 cited
Liraglutide 3.0mg improves body weight and cardiometabolic risk factors in overweight or obese adults without diabetes: The SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 56-week trial
Obesity Research & Clinical Practice·2014· 5 cited
Brown adipose tissue: what have we learned since its recent identification in human adults
Arquivos Brasileiros de Endocrinologia & Metabologia·2014· 22 citedOpen Access
Efficacy and safety of liraglutide 3.0mg for weight management in overweight and obese adults: The SCALE Obesity and Prediabetes, a randomised, double-blind and placebo-controlled trial
Obesity Research & Clinical Practice·2014· 7 cited
Untitled
International Journal of Orofacial Myology·2014Open Access
The masticatory system of the obese: Clinical and electromyographic evaluation
International Journal of Orofacial Myology·2014· 3 citedOpen Access
Changes in Neuropsychological Tests and Brain Metabolism After Bariatric Surgery
The Journal of Clinical Endocrinology & Metabolism·2014· 54 citedOpen Access
Obesidade na mulher
RBM. Revista brasileira de medicina·2014· 1 cited
page 1 of 11Next →

Frequent Co-authors

Márcio C. Mancini(17), S M Villares(8), Cíntia Cercato(7), Ivani C. Trombetta(5), Carlos Eduardo Negrão(5), Maria Edna de Melo(5), Sérgio Vencio(5), Arthur B. Garrido(4), Aureo L. DePaula(4), L. T. Batalha(4), Maria Urbana Pinto Brandão Rondon(4), Antônio Carlos Pereira Barretto(4), Marco Aurélio Santo(4), Alessandro R. Stival(4), Arne Astrup(3), John Wilding(3), Cláudia P. Oliveira(3), Denise Cerqueira Paranaguá‐Vezozzo(3), Mateus Camaroti Laterza(3), Bruno Zilberstein(3)